BSAC Infection Learning Hub
Open access global learning
All courses accredited

Antimicrobial Surveillance and consumption data – how, what and why to measure to provide meaningful data

Thursday 17 September 2020, 1700-1800hrs (GMT)

CPD accredited

Co-chairs: Mark Gilchrist, London & Jacqueline Sneddon

This webinar will consist of the following presentations:

What can National surveillance data tell you?

How can Point Prevalence Studies help you understand antimicrobial use?

Translating the idea of PPS into practice – experiences of Scottish/ Ghanaian Partnership

Q&A Panel session
All speakers

  • Dr Jacqueline Sneddon, Project Lead for Scottish Antimicrobial Prescribing Group Healthcare Improvement Scotland

    Project Lead for national antimicrobial stewardship programme since 2008. Has led development of education resources on antimicrobial stewardship, prescribing quality indicators, development of national consensus on antimicrobial policies and development of a national antimicrobial app. Founder member of the Association of Scottish Antimicrobial Pharmacists, Chair of the UKCPA Pharmacy Infection Network 2015-18 and currently Chair of the RPS Antimicrobial Expert Advisory Group. In 2019-20 Lead UK Partner for Fleming Fund Commonwealth Partnerships for Antimicrobial Stewardship (AMS) global volunteering grant. This work is supporting two hospitals in Ghana to establish multi-professional antimicrobial stewardship programmes.

  • Mark Gilchrist, Consultant Pharmacist Infectious Diseases & Stewardship, OPAT service lead at Imperial College Healthcare NHS Trust

    Mark is a council member of British Society of Antimicrobial Chemotherapy and co-leads its UK OPAT Initiative. He is a senior honorary lecturer at Imperial College London, together with being a spokesman on antimicrobials and fellow of the Royal Pharmaceutical Society.

    Mark has particular interests in antimicrobial stewardship around improving systems and processes that affect local, national and international AMR. His clinical interests include OPAT, tuberculosis and critical care.

    Postgraduate education includes an MSc and non-medical independent prescribing status and he was recently awarded the NHS Leadership Academy Nye Bevan Award in executive healthcare leadership. He is past chair of the UK Clinical Pharmacy Association – Pharmacy Infection Network (UKCPA PIN) and was awarded RPS Faculty Fellowship (Infection) in 2013.

    He has delivered many lectures and workshops on AMS both at national and international level and has published around his areas of interest.

Reference materials